Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical practice. Alpha1-antitrypsin deficiency.

Literature DB >> 19553648

Clinical practice. Alpha1-antitrypsin deficiency.

Edwin K Silverman¹, Robert A Sandhaus.

Abstract

Entities: Gene

Mesh：

Substances：
alpha 1-Antitrypsin

Year: 2009 PMID： 19553648 DOI： 10.1056/NEJMcp0900449

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

120 in total

1. Identification of a chronic obstructive pulmonary disease genetic determinant that regulates HHIP.

Authors: Xiaobo Zhou; Rebecca M Baron; Megan Hardin; Michael H Cho; Jan Zielinski; Iwona Hawrylkiewicz; Pawel Sliwinski; Craig P Hersh; John D Mancini; Ke Lu; Derek Thibault; Amy L Donahue; Barbara J Klanderman; Bernard Rosner; Benjamin A Raby; Quan Lu; Adriana M Geldart; Matthew D Layne; Mark A Perrella; Scott T Weiss; Augustine M K Choi; Edwin K Silverman
Journal: Hum Mol Genet Date: 2011-12-02 Impact factor: 6.150

2. A challenging diagnosis of alpha-1-antitrypsin deficiency: identification of a patient with a novel F/Null phenotype.

Authors: Michael R Ringenbach; Erin Banta; Melissa R Snyder; Timothy J Craig; Faoud T Ishmael
Journal: Allergy Asthma Clin Immunol Date: 2011-11-13 Impact factor: 3.406

Review 3. Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors: Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal: Pharmacol Rev Date: 2010-12 Impact factor: 25.468

4. Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline.

Authors: Darcy D Marciniuk; P Hernandez; M Balter; J Bourbeau; K R Chapman; G T Ford; J L Lauzon; F Maltais; D E O'Donnell; D Goodridge; C Strange; A J Cave; K Curren; S Muthuri
Journal: Can Respir J Date: 2012 Mar-Apr Impact factor: 2.409

10. Recombinant Adeno-Associated Virus Vector Genomes Take the Form of Long-Lived, Transcriptionally Competent Episomes in Human Muscle.

Authors: Bruce C Schnepp; Jeffrey D Chulay; Guo-Jie Ye; Terence R Flotte; Bruce C Trapnell; Philip R Johnson
Journal: Hum Gene Ther Date: 2016-01 Impact factor: 5.695

Clinical practice. Alpha1-antitrypsin deficiency.

1. Identification of a chronic obstructive pulmonary disease genetic determinant that regulates HHIP.

2. A challenging diagnosis of alpha-1-antitrypsin deficiency: identification of a patient with a novel F/Null phenotype.

Review 3. Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

4. Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline.

Review 5. The Art and Science of Diagnosing and Treating Lung and Heart Disease Secondary to Liver Disease.

6. Real time PCR detection of the PIZ and PIS mutations associated with alpha-1 antitrypsin deficiency.

Review 7. Next generation treatment of acute graft-versus-host disease.

Review 8. Risk of Lung Disease in PI MZ Heterozygotes. Current Status and Future Research Directions.

Review 9. Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

10. Recombinant Adeno-Associated Virus Vector Genomes Take the Form of Long-Lived, Transcriptionally Competent Episomes in Human Muscle.

Clinical practice. Alpha1-antitrypsin deficiency.

1. Identification of a chronic obstructive pulmonary disease genetic determinant that regulates HHIP.

2. A challenging diagnosis of alpha-1-antitrypsin deficiency: identification of a patient with a novel F/Null phenotype.

Review 3. Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

4. Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline.

Review 5. The Art and Science of Diagnosing and Treating Lung and Heart Disease Secondary to Liver Disease.

6. Real time PCR detection of the PI*Z and PI*S mutations associated with alpha-1 antitrypsin deficiency.

Review 7. Next generation treatment of acute graft-versus-host disease.

Review 8. Risk of Lung Disease in PI MZ Heterozygotes. Current Status and Future Research Directions.

Review 9. Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

10. Recombinant Adeno-Associated Virus Vector Genomes Take the Form of Long-Lived, Transcriptionally Competent Episomes in Human Muscle.

6. Real time PCR detection of the PIZ and PIS mutations associated with alpha-1 antitrypsin deficiency.